비타민 D3 츄어블, 비타민 D3 액상, 비타민 D3 파우더, 비타민 D3 소프트젤, +1
최종 업데이트
2026-06-01
서치 및 소싱 팀을 위한 핵심 요약
비타민 D3 보충제 마켓 커버리지는 64개 국가에 걸쳐 있습니다.
이 제품에 대해 글로벌 공급망 인텔리전스 네트워크에 수출업체 1,074개와 수입업체 1,255개가 색인되어 있습니다.
1,834건의 공급업체 연계 거래가 상위 20개 국가에 걸쳐 요약되어 있습니다.
현재 프리미엄 공급업체 0개와 카탈로그 항목 0개가 등록되어 있습니다.
도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
페이지 데이터 최종 업데이트일: 2026-06-01.
비타민 D3 보충제에 대한 글로벌 공급업체 거래, 수출 활동 및 가격 벤치마크
상위 20개 국가에 걸친 공급업체 연계 거래 1,834건을 분석하고, 월간 단가 벤치마크로 비타민 D3 보충제의 수출 경쟁력과 소싱 리스크를 추적하세요.
비타민 D3 보충제 국가별 공급업체 거래 및 수출 모멘텀 전년 대비 변화
비타민 D3 보충제의 긍정적/부정적 전년 대비 변화를 비교해 성장하는 공급 시장과 약화되는 수출 경로를 식별하세요.
비타민 D3 보충제의 YoY 변동 상위 국가는 영국 (+389.7%), 코스타리카 (+233.6%), 이탈리아 (+193.3%)입니다.
비타민 D3 보충제 국가별 공급업체 거래 및 단가 요약
2025-07 기준으로 비타민 D3 보충제 국가별 거래 건수와 월간 단가/물량을 비교해 공급업체 및 수출 시장 우선순위를 정하세요.
2025-12 기준, 노출 가능한 비타민 D3 보충제 거래 단가가 있는 국가는 이탈리아 (1100.00 USD / kg), 콜롬비아 (330.34 USD / kg), 싱가포르 (175.00 USD / kg), 아랍에미리트 (148.03 USD / kg), 과테말라 (141.72 USD / kg), 외 14개국입니다.
Vitamin D3 (cholecalciferol) supplements are globally traded, finished “dose form” nutrition products sold as capsules, tablets, powders, and measured liquid solutions. Internationally, this category is shaped by regulatory regimes that may treat these products as foods/food supplements (e.g., Codex guideline scope and EU food supplement rules) and by manufacturing quality expectations (e.g., dietary supplement cGMP requirements in the United States). Product quality in trade is commonly anchored by pharmacopeial specifications for identity and potency of cholecalciferol and common dosage forms, alongside label-claim compliance. Product-specific trade quantification is often challenging because customs data typically tracks broader Harmonized System product groupings rather than “vitamin D3 supplements” as a single globally uniform line item.
Specification
Major VarietiesCholecalciferol (Vitamin D3)
Physical Attributes
Fat-soluble vitamin supplied as a concentrated nutrient in “dose forms” such as capsules, tablets, powders, and solutions (regulatory definitions in Codex guideline and EU food supplements directive).
Compositional Metrics
USP dietary supplement monograph: Cholecalciferol contains NLT 97.0% and NMT 103.0% of cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Tablets contain NLT 90.0% and NMT 115.0% of the labeled amount of cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Capsules contain NLT 90.0% and NMT 110.0% of the labeled amount of vitamin D as cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Solution contains NLT 90.0% and NMT 120.0% of the labeled amount of vitamin D as cholecalciferol.
Grades
Pharmacopeial quality compliance (e.g., USP–NF dietary supplement monographs for cholecalciferol and relevant dosage forms) used as a specification anchor in some markets.
Packaging
Pre-packaged “dose form” presentations such as capsules, tablets/pills, powders in small-unit formats, and measured liquid forms (e.g., drop-dispensing bottles) are common in regulated markets.
ProcessingOil-based solutions and oil-filled capsule formats are common; USP recognizes cholecalciferol solutions in edible vegetable oil and certain solubilizing/solvent systems for solution dosage forms.
Supply Chain
Value Chain
Cholecalciferol ingredient sourcing → incoming component/label/packaging controls and identity testing → formulation (including oil-based solutions where applicable) → encapsulation/tableting → packaging & labeling → finished-product testing and release → holding & distribution under dietary supplement cGMP expectations (where applicable).
Demand Drivers
Used as a dietary supplement source of vitamin D (calciferol) to supplement dietary intake, including in products marketed as vitamin/mineral food supplements where regulated as foods.
Risks
Regulatory Compliance HighVitamin D3 supplements face high trade disruption risk from regulatory non-compliance (e.g., labeling, composition, and manufacturing control expectations). Jurisdictions vary in whether these products are regulated as foods/food supplements versus medicinal products, and enforcement actions (e.g., detentions, market withdrawals, recalls) can rapidly interrupt cross-border flows for non-compliant lots.Align formulation and labeling to destination-market rules; operate under appropriate GMP/cGMP systems; maintain robust identity/potency verification and documentation for components, packaging, labels, and finished lots.
Quality Variability MediumLabel-claim accuracy and potency conformance are central quality risks because vitamin D3 supplements are sold in concentrated dose forms and must meet stated labeled amounts. Pharmacopeial monographs specify acceptable assay ranges for cholecalciferol and common finished forms (tablets, capsules, solutions), and deviations can trigger rework, rejection, or compliance findings.Specify pharmacopeial-grade inputs where feasible; use validated assay methods and reference standards; implement batch-release testing to confirm labeled-amount conformance.
Trade Data Visibility MediumMarket intelligence and risk monitoring can be impaired because customs and trade databases classify products using Harmonized System groupings, and “vitamin D3 supplements” may be embedded within broader lines. This limits transparency on product-specific trade flows and can obscure sudden shifts in supplier or route concentration.Use a consistent HS scoping approach with product descriptions and ingredient identifiers; triangulate trade statistics with regulatory registrations and supplier qualification data.
FAQ
How is vitamin D3 typically sold in international supplement markets?Vitamin D3 supplements are commonly sold in pre-packaged “dose forms” such as capsules, tablets/pills, powders, and measured liquid solutions. This matches the product forms described in Codex guidance for vitamin/mineral food supplements and the EU definition of food supplements as dose-form products.
What standards are commonly used to define vitamin D3 supplement quality and potency?Pharmacopeial monographs are a common anchor for identity and potency expectations, and USP–NF includes dietary supplement monographs for cholecalciferol and for finished forms like tablets, capsules, and solutions. These monographs specify acceptable assay ranges around labeled amounts for those dosage forms.
What is the biggest compliance risk for vitamin D3 supplements in cross-border trade?The biggest risk is regulatory non-compliance, because food supplement rules and enforcement expectations differ by jurisdiction and can result in detentions, withdrawals, or recalls. Codex notes that its guideline applies where these products are regulated as foods, and major markets also impose manufacturing-control expectations such as dietary supplement cGMP requirements in the United States.